The relationship between Testosterone Replacement Therapy (TRT) and diabetes management continues to be a dynamic area of research. Recent studies from 2024 and 2025 are providing a more nuanced understanding of TRT's role in glycemic control and the prevention of type 2 diabetes (T2D).
TRT and Glycemic Control: A Mixed Picture
While some studies have shown promising results, the overall picture regarding TRT and glycemic control is mixed. A 2024 study in JAMA Internal Medicine found that TRT did not significantly improve glycemic control in men with prediabetes or diabetes. However, other research, such as a 2024 study in Diabetes, Obesity and Metabolism, suggests that TRT can reduce insulin resistance in men with metabolic syndrome.
Prevention of Type 2 Diabetes
The potential for TRT to prevent the progression from prediabetes to T2D is a key area of investigation. A 2024 review in the Journal of Clinical Endocrinology & Metabolism evaluated recent randomized controlled trials on this topic. The findings suggest that while TRT may have a role in high-risk individuals, it is not a universal solution for T2D prevention.
| Research Area | Key Findings | Implication |
|---|---|---|
| Glycemic Control | Mixed results, may not improve in all patients | TRT is not a one-size-fits-all solution |
| T2D Prevention | Potential role in high-risk individuals | Further research needed to identify responders |
| Cardiovascular Safety | Reassuring data from the TRAVERSE trial | TRT is safe from a cardiovascular standpoint |
Cardiovascular Safety of TRT
The cardiovascular safety of TRT has been a long-standing concern. The TRAVERSE trial, a large-scale study on this topic, has provided reassuring data. The results, published in 2026, indicate that TRT is not associated with an increased risk of major adverse cardiovascular events, which is a critical consideration for men with diabetes who are already at a higher cardiovascular risk.
Key Takeaways
- The effect of TRT on glycemic control is not uniform and may depend on individual patient characteristics.
- TRT may have a role in preventing T2D in certain high-risk men, but more research is needed.
- The cardiovascular safety of TRT has been largely established, providing reassurance for its use in appropriate patients.
References
- Bhasin, S., et al. (2024). Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Overweight or Obesity and Low Testosterone. JAMA Internal Medicine, 184(4), 371–380. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2814401
- Wittert, G. (2024). Testosterone and the prevention of type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/39285839/
Medical Disclaimer: The information in this article is for educational purposes only and is not intended as a substitute for professional medical advice. Always consult with a qualified healthcare provider before making any decisions about your health or treatment.
